*Toshikuni Sasaoka¹, Nae Saito¹, Satomi Chiken², Manabu Abe¹, Meiko Kawamura¹, Yoko Nabeshima³, Yo-ichi Nabeshima³, Kazuki Tainaka¹, Kenji Sakimura¹, Atsushi Nambu² (1. Brain Research Institute, Niigata University, 2. National Institute for Physiological Sciences, 3. Foundation for Biomedical Research and Innovation at Kobe)

*WENTING LI¹, Yoshio Goshima², Toshio Ohshima¹ (1. Waseda University, 2. Yokohama City University)

*Shunya Inukai¹, Satoshi Hara¹, Hiroshi Ichinose¹ (1. Tokyo Institute of Technology, School of Life Science and Technology)

*Yuri Ikeda-Matsuo¹, Nobutaka Miyahara¹, Norika Yunoki¹, Chika Yozawa², Satoshi Uematsu³, Shizuo Akira⁴, Tatsuo Takahashi¹, Mitsuo Tanabe² (1. Hokuriku Univ, 2. Kitasato Univ, 3. Osaka City Univ, 4. Osaka Univ)

*Mariko Noda¹, Ikuko Iwamoto¹, Hidenori Tabata¹, Hidenori Ito¹, Kouichi Nagata¹ (1. Institute for Developmental Research, Aichi Developmental Disability Center (ADDC))

*Keigo Tamakoshi¹, Madoka Maeda², Shinnosuke Nakamura³, Nae Murohashi¹ (1. Niigata University of Health and Welfare, 2. Kuwana Hospital, 3. Iwamuro Rehabilitation Hospital)

*Ayaka SUGENO Sugeno^1,2, Wenhui Piao¹, Miki Yamazaki^1,2, Kiyofumi Takahashi³, Hiroko Matsunaga³, Masahito Hosokawa^3,4, Daisuke Tominaga^2,5, Yoshio Goshima⁶, Haruko Takeyama^1,2,3,4, Toshio Ohshima^1,4 (1. Life Science and Medical Bioscience Dept.,Waseda Univ. , 2. CBBD-OIL, Waseda-AIST, 3. Research Organization for Nano and Life Innovation, Waseda, 4. Institute for Advanced Research of Biosystem Dynamics, Waseda, 5. Cellular and Molecular Biotechnology Research Inst., AIST, 6. Molecular Pharmacology and Neurobiology Dept., Yokohama City Univ.)